Trial intelligence / Profile preview

Premixed insulin lispro versus basal-bolus insulin in adults with type 2 diabetes and a light breakfast

2007-005061-36Phase 4Completed

Sponsor
Eli Lilly and Company
Start
Dec 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of insulin lispro mix25, insulin lispro + insulin lispro protamine, human insulin and insulin glargine in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Eli Lilly and Company. Started Dec 2007; status: completed.

02

Drugs

insulin lispro mix25insulin lispro + insulin lispro protaminehuman insulininsulin glargine
03

Conditions

type 2 diabetes mellitus (T2DM)

Beyond the preview

Go deeper on 2007-005061-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-005061-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call